Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Jude Ogechukwu Okoye 1 Article
Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review
Jude Ogechukwu Okoye, Chukwudi Amaechi Ofodile, Oluwaseun Kelechi Adeleke, Okechi Obioma
Epidemiol Health. 2021;43:e2021039.   Published online May 25, 2021
DOI: https://doi.org/10.4178/epih.e2021039
  • 6,748 View
  • 281 Download
  • 7 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES
This review assessed the rate of high-risk human papillomavirus (HPV) infection among women living in sub-Saharan Africa. It also determined the prevalence of high-risk HPV (hrHPV) among human immunodeficiency virus (HIV) seropositive (HIV+) and seronegative (HIV-) women in sub-Saharan Africa, pre-2010 and post-2010.
METHODS
In this systematic review, Google Scholar, PubMed Central, and Embase were searched to identify cohort and case-control studies that investigated the relationship between HIV and HPV infection. The database searches yielded 17 studies published between 1999 and 2018.
RESULTS
In the general population, the prevalence of any HPV/multiple HPV infections was higher among HIV+ (53.6/22.6%) than among HIV- women (26.5/7.3%) with odds ratios of 3.22 and 3.71, respectively (95% confidence interval, 3.00 to 3.42 and 2.39 to 5.75, p< 0.001). The prevalent HPV genotypes among HIV+ and HIV- women diagnosed with invasive cervical cancer (ICC) were HPV-16/18 and HPV-45. The prevalence of HPV-16, HPV-18, and HPV-45 was lower in 1999-2010 (3.8, 1.7, and 0.8%, respectively) than in 2011-2018 (19.1, 6.0, and 3.6%, respectively). Among women diagnosed with ICC, HIV+ women had a higher prevalence of HPV-56, HPV-31, and HPV-51 (7.3, 5.3, and 3.3%, respectively) than HIV- women (1.3, 2.2, and 0.4%, p< 0.001, p= 0.050, and p= 0.013, respectively).
CONCLUSIONS
The prevalence of HPV infection, multiple HPV infections, and non-vaccine HPV types were higher among HIV+ women than among HIV- women in sub-Saharan Africa. Although HIV infection influences the distribution of HPV types, this study suggests that cervical cancer incidence in sub-Saharan Africa is primarily driven by the prevalence of vaccine hrHPVs, especially HPV-16 and HPV-18.
Summary
Korean summary
Key Message
Despite increasing awareness of Human papillomavirus (HPV) among women and availability of HPV vaccines, mounting evidence shows that the age-standardized incidence rate of cervical cancer is increasing in sub-Saharan Africa. This review revealed the influences of some viruses on the trends of the disease between 1999-2010 and 2011-2018.

Citations

Citations to this article as recorded by  
  • Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
    Crispin Kahesa, Louise T. Thomsen, Ditte S. Linde, Bariki Mchome, Johnson Katanga, Patricia Swai, Rachel Manongi, Myassa Kjaerem, Thomas Iftner, Marianne Waldstrøm, Julius Mwaiselage, Vibeke Rasch, Susanne K. Kjær
    International Journal of Cancer.2023; 152(4): 686.     CrossRef
  • Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries
    Jessica Joseph, Owen Demke, Lola Ameyan, Joseph Bitilinyu-Bango, Blandine Bourgoin, Mamadou Diop, Babacar Guèye, Jibrin Kama, Marvin Lubega, Bernard Madzima, Tatenda Maparo, Tasimba Mhizha, Andrew Musoke, Susan Nabadda, Twambilire Phiri, Timothy Tchereni,
    BMJ Open.2023; 13(1): e065074.     CrossRef
  • HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring
    Nancy McClung, Anikie Mathoma, Julia W. Gargano, Naledi Gape Nyepetsi, Troy D. Querec, Juanita Onyekwuluje, Madisa Mine, Chelsea Morroni, Rebecca Luckett, Lauri E. Markowitz, Doreen Ramogola-Masire
    BMC Infectious Diseases.2022;[Epub]     CrossRef
  • Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment
    Tara Herrick, Kerry A. Thomson, Michelle Shin, Sarah Gannon, Vivien Tsu, Silvia de Sanjosé
    BMC Health Services Research.2022;[Epub]     CrossRef
  • The preference of women living with HIV for the HPV self-sampling of urine at a rural HIV clinic in Uganda
    Agnes Nyabigambo, Roy W. Mayega, Hilbert Mendoza, Aslam Shiraz, John Doorbar, Lynn Atuyambe, Themba G. Ginindza
    Southern African Journal of Infectious Diseases.2022;[Epub]     CrossRef
  • Cervical cancer prevention and control in women living with human immunodeficiency virus
    Philip E. Castle, Mark H. Einstein, Vikrant V. Sahasrabuddhe
    CA: A Cancer Journal for Clinicians.2021; 71(6): 505.     CrossRef
  • Exogenous Vimentin Supplementation Transiently Affects Early Steps during HPV16 Pseudovirus Infection
    Sinead Carse, Dirk Lang, Arieh A. Katz, Georgia Schäfer
    Viruses.2021; 13(12): 2471.     CrossRef

Epidemiol Health : Epidemiology and Health